With a strong background in technology and healthcare investments, the fund manager has successfully completed over 30 deals across North America and Europe. Emphasizing a data-driven approach, they have built a diverse portfolio with notable exits in biotech and software sectors. Their strategic style leans towards early-stage investments, identifying disruptive trends that drive growth. This extensive experience highlights their ability to navigate complex markets and generate value for stakeholders.